Back to search

Switzerland· 61631001

Moviprep Orange, Pulver

A macrogol, kombinationen product containing macrogolum 3350, natrii sulfas anhydricus, natrii chloridum, kalii chloridum, acidum ascorbicum, natrii ascorbas, registered in Switzerland by Norgine AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC A06AD65

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedMoviprep Orange, PulverATCA06AD65REGISTER NO.61631001PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Macrogol, kombinationen is registered in 11 of 19 countries.

Countries holding a registration under ATC A06AD65 (macrogol, kombinationen), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 7 of them publish a price we can compare per daily dose

Macrogol, kombinationen · ATC A06AD65

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
macrogolum 3350, natrii sulfas anhydricus, natrii chloridum, kalii chloridum, acidum ascorbicum, natrii ascorbas
Manufacturer
Norgine AG
Country
Switzerland (CH)
ATC code
A06AD65
ATC class
Macrogol, Kombinationen
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680616310019
    Dppl Btl 2 Stk
    CHF 28.95

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

449 interactions on record for macrogol, kombinationen.

Graded by severity as the source publishes them — 37 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Macrogol, kombinationen · interactions on record

449 records

  • 37 severe
  • 411 moderate
  • 1 minor

Most severe, free to view

  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • QuinidineC01BA01severe
  • ProcainamideC01BA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d2497fa4-6b97-42fb-b30d-e7ba6ea4ee80
GET /v1/drugs/d2497fa4-6b97-42fb-b30d-e7ba6ea4ee80?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "macrogolum 3350 100 g + natrii sulfas anhydricus 7.5 g + natrii chloridum 2.691 g + kalii chloridum 1.015 g + acidum ascorbicum (vitamin c, e300) 4.7 g + natrii ascorbas (e301) 5.9 g",
  "valid_from": "2012-01-01",
  "limitations": null,
  "galenic_form": "Plv 2Btl A+2Btl B",
  "therapeutic_area": null,
  "sl_inclusion_date": "2012-01-01",
  "self_retention_pct": 10
}

See everything about macrogol, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.